Nested Therapeutics launches with $125m for precision cancer therapies; The Cambridge startup is mapping genetic mutations in 3D to uncover commonalities between seemingly rare causes of the disease.

Media coverage

• Title	Nested Therapeutics launches with $125m for precision cancer therapies; The Cambridge startup is mapping genetic mutations in 3D to uncover commonalities between seemingly rare causes of the disease.
  Media name/outlet	The Boston Globe
  Country/Territory	United States
  Date	7/10/22
  URL	ct.moreover.com/?a=48931451222&p=1gw&v=1&x=A37XR4KQxsMeT1p_tRLLXQ
  Persons	Arvin Dar

• Title	Nested Therapeutics launches with $125m for precision cancer therapies; The Cambridge startup is mapping genetic mutations in 3D to uncover commonalities between seemingly rare causes of the disease.
  Media name/outlet	bostonglobe.com
  Country/Territory	United States
  Date	6/10/22
  URL	ct.moreover.com/?a=48927506226&p=1gw&v=1&x=NGuf3I-RCZKLP_CcoVGiGQ
  Persons	Arvin Dar